Health care stocks were rising premarket Wednesday, with The Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) up 0.5%
Novo Nordisk (NVO) and Septerna (SEPN) said they will collaborate on a project to develop and commercialize oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases. Shares of Septerna were up past 68% while Novo Nordisk stock was over 2% higher pre-bell.
GSK (GSK) has agreed to acquire Boston Pharmaceuticals' investigational steatotic liver disease treatment efimosfermin alfa for up to $2 billion in cash, the companies said. GSK shares were up over 1% premarket.
Scholar Rock (SRRK) shares were up 0.9% even after the company reported a wider Q1 net loss.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.